SMTL ID : 8s53.1

X-ray crystal structure of CYP142 from Mycobacterium tuberculosis in complex with a fragment bound in two poses

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

2 x 3QO: 4-benzylpyridine(Non-covalent)

3QO.1: 16 residues within 4Å: Chain A: I.85, L.92, M.94, I.96, V.180, L.183, L.246, I.249, G.250, T.254, V.297, M.300, F.400, V.401 Ligands: 3QO.2, HEM.3 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.85, A:I.96, A:L.183, A:L.246, A:T.254, A:V.297, A:F.400, A:F.400 3QO.2: 11 residues within 4Å: Chain A: L.92, M.94, L.179, F.182, L.183, T.195, M.196, F.199, M.242, L.245 Ligands: 3QO.1 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.92, A:L.179, A:F.182, A:L.245

1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.3: 35 residues within 4Å: Chain A: E.73, M.95, I.96, H.103, R.107, F.114, I.158, M.161, L.246, I.247, G.250, G.251, T.254, T.255, T.258, L.291, P.296, V.297, M.300, R.302, F.325, A.352, F.353, G.354, F.355, T.357, H.358, F.359, C.360, L.361, G.362, L.365, A.366, L.370 Ligands: 3QO.1 22 PLIP interactions: 22 interactions with chain A, Hydrophobic interactions: A:I.96, A:F.114, A:I.158, A:L.246, A:I.247, A:L.291, A:V.297, A:V.297, A:F.325, A:F.353, A:F.353, A:L.361, A:L.365, A:A.366 Hydrogen bonds: A:F.355 Water bridges: A:R.302, A:H.358 Salt bridges: A:H.103, A:R.107, A:R.302, A:H.358 Metal complexes: A:C.360

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kavanagh, M.E. et al., Fragment-based development of small molecule inhibitors targeting Mycobacterium tuberculosis cholesterol metabolism. Biorxiv (2024)

Release Date

2025-01-29

Peptides

Steroid C26-monooxygenase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Steroid C26-monooxygenase

Related Entries With Identical Sequence